SOAT1 and hepatocellular carcinoma: Further, in all four HCC cell lines, we observed basal activation of IFN-I signaling mediators with constitutive activation of ISG expression, and GE treatment inhibited both the activation of molecules in the JAK/STAT pathway as well as ISG mRNA expression, albeit at a variable level.